ScreenPro FH
Screening Project for Familial Hypercholesterolemia
in Central, Southern and Eastern Europe

News

We are thrilled to announce the release of an insightful video lecture titled “Navigating the New Frontiers in Homozygous FH Care” by Professor Peter Lansberg. In this engaging presentation, he delves deep into the complexities of HoFH, offering valuable insights into its diagnosis, management, and treatment options.

Understanding HoFH: Professor Lansberg begins by discussing when to consider HoFH in patients with FH. He sheds light on the key criteria for diagnosing HoFH, providing clinicians with essential guidance on identifying this severe form of hypercholesterolemia.

Managing HoFH Patients: One of the highlights of the lecture is Professor Lansberg’s comprehensive exploration of the management strategies for HoFH patients.

Insights from the Netherlands: Drawing from experiences in the Netherlands, Professor Lansberg presents a compelling case report about an 8-year-old boy, offering real-world perspectives on diagnosing and treating HoFH.

Roadmap FH: In the culmination of the presentation, Professor Lansberg focuses on paper from Global Heart Journal. This paper, which outlines treatment guidelines for FH from the IAS, provides intriguing insights into general strategies, healthcare system setup, and infrastructure required to ensure the accurate diagnosis of FH patients.

Watch the video here:

More → Category: Homepage 1, News
25. March, 2024

The International Atherosclerosis Society and the European Atherosclerosis Society have recently unveiled updated guidelines on FH and Homozygous FH. The IAS has recently published evidence-informed guidance for implementing best practices in the care of Familial Hypercholesterolaemia (FH). This comprehensive guidance aims to benefit individuals with FH across different countries. 

Read the full IAS guidelines HERE.

The EAS has also released an updated consensus statement specifically addressing Homozygous Familial Hypercholesterolaemia (HoFH). This statement provides new treatments and clinical guidance for HoFH. It explains the genetic complexity of HoFH and offers pragmatic recommendations to address inequities in HoFH care worldwide.  Read the full EAS guidelines HERE.

More → Category: Homepage 3, News
18. September, 2023
6. June, 2023

The 37th World Congress of Internal Medicine (WCIM) is coming to Prague from October 30th to November 2nd, 2024. As one of the largest international meetings in the field, it will cover topics like cardiology and lipidology, attracting experts and healthcare professionals from around the world.

Prague’s rich history and vibrant culture provide an ideal backdrop for this prestigious event, offering attendees a unique blend of academic exchange and cultural exploration.

For more information about the congress and registration, please visit the website: www.wcim2024.com.

More → Category: Homepage 2, Meetings, News

The ScreenPro FH Project has gained another country leader from Slovenia. Urh Groselj, MD, PhD, MA from UMC – University Children’s Hospital Ljubljana together with his team are dedicated to improving the prevention and control of raised cholesterol in children through their work on FH pediatric screening. Their efforts have been recognized in a World Heart Federation white paper titled “Improving Prevention and Control of Raised Cholesterol.” The paper highlights the challenge of FH remaining largely undiagnosed due to a lack of public and health professional awareness, leading to a significant increase in the risk of atherosclerosis and cardiovascular disease in early adulthood for those with undiagnosed or untreated FH. Please find an extrat of the article below:

More → Category: News